International consulting firm PricewaterhouseCoopers says biotechnology companies must collaborate to produce more efficient and cost-effective medicines or face extinction in a new report called Biotech Reinvented.

NovoLogix Inc. is not the easiest company to understand. But it does have a colorful past and an intriguing future.Once a $400 million force in the home-health care market, the former Ancillary Care Management has remade itself into a software-as-a-service company that focuses on helping payers manage claims relating to fast growing demand for expensive [...]